Porton Advanced Solutions announced a strategic cooperation with Suzhou Royaltech Med Co., Ltd that will promote the establishment of microbial vectors used for gene therapy and mRNA drug platform technology, and accelerate the R&D process of bioinnovative drugs.
[Porton Advanced Solutions (Cision US, Inc.)]